Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

John H. Kimbrough, PhD

Research Scientist
JMI Laboratories

Disclosure(s): AbbVie: Grant/Research Support; GSK: Grant/Research Support

Poster(s):

125 - Induction of Resistance Against Antipseudomonal Agents: Comparison of Novel b-Lactam/b-Lactamase Inhibitor (BL/BLI) Combinations and Other b-lactam Agents
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET
641 - Activity of Gepotidacin Tested Against Molecularly Characterized Escherichia coli Isolates Resistant to Commonly Used Oral Therapies for UTI in the US (2019-2020)
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET
642 - In Vitro Activity of Cefiderocol and Comparator Agents Against Molecularly Characterized Enterobacterales Clinical Isolates Causing Infection in United States Hospitals (2020-2021)
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET